Article info
PDFMeeting Report
Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference
- ↵a abot{at}kitepharma.com
- ↵b maurizio.chiriva{at}ttuhsc.edu
- ↵c andrew.cornforth{at}californiastemcell.com
- ↵d brian.czerniecki{at}uphs.upenn.edu
- ↵e SFERRONE{at}PARTNERS.ORG
- ↵f ken.geles{at}pfizer.com
- ↵g pgreen{at}u.washington.edu
- ↵h hurte{at}medimmune.com
- ↵i Richard.Koya{at}RoswellPark.org
- ↵j mmanjili{at}vcu.edu
- ↵k matsuwi{at}jhmi.edu
- ↵l RMorgan{at}bluebirdbio.com
- ↵m palenac{at}mail.nih.gov
- ↵n poda{at}mail.med.upenn.edu
- ↵o restifo{at}nih.gov
- ↵p dspencer{at}bellicum.com
- ↵q raul{at}rcai.riken.jp
- ↵r ajwong{at}stanford.edu
- ↵s liliyang{at}mednet.ucla.edu
- ↵t John.Yu{at}cshs.org
Citation
Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference
Publication history
- Received December 26, 2013
- Accepted March 12, 2014
- First published March 20, 2014.
Online issue publication
February 09, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© The Author(s). 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.